The latest iPhone conversation has shifted from whether Apple is exploring a foldable to what the device might be called and when it could appear. Supply-chain reporting describes a premium-focused 2026 launch strategy, while newer coverage says the internal shorthand may be ‘Ultra’. Apple has announced none of this.
- What is supported by reporting
- Fold and Ultra are not official names
- The questions that matter more than the name
- VerdictLab’s buyer guidance
What is supported by reporting
Reuters summarized Nikkei Asia reporting that Apple was prioritizing three high-end iPhone models for the second half of 2026: two conventional premium phones and its first foldable, while the standard iPhone 18 could move to 2027. Reuters said it could not independently verify the report, an important limitation.

Fold and Ultra are not official names
Recent specialist coverage says ‘Ultra’ is used internally, while the public has commonly adopted ‘iPhone Fold’. Neither label appears in Apple’s newsroom. A codename can describe position in a lineup without becoming the final retail name, so headlines should not present either as confirmed.
The questions that matter more than the name
A first-generation foldable must prove hinge durability, crease visibility, battery life, app continuity, repair cost and regional availability. A premium name cannot answer those questions. Buyers should also compare the device with mature foldables already on the market rather than treating Apple’s entry as a new category.
VerdictLab’s buyer guidance
Do not plan a purchase around leaked names, dates or prices. Wait for Apple’s event, then check official specifications, warranty and local availability. If the device is announced, the strongest early review will separate demonstrable hardware facts from first-impression novelty and long-term durability claims.
A frequently repeated product name is still a rumor until the manufacturer publishes it.
VerdictLab editorial note
Original sources
This VerdictLab report is an original summary and analysis based on the reporting below.
How this was created: VerdictLab selected and checked the cited reporting, prepared an original summary with AI assistance, and translated it for accessibility. We link to the original publishers and do not reproduce their articles.